| Name | RDN2150 |
|---|
| Description | RDN2150 (Compound 25) is a ZAP-70 inhibitor (IC50: 14.6 nM). RDN2150 covalently binds to the C346 residue of ZAP-70. RDN2150 inhibits the expression of CD25 and CD69, and inhibits CD4+ T cell activation. RDN2150 can be used for research of psoriasis[1]. |
|---|---|
| Related Catalog | |
| Target |
14.6 nM (ZAP-70)[1] |
| References |
| Molecular Formula | C28H29ClN8O4 |
|---|---|
| Molecular Weight | 577.03 |